首页 › 股票 › GENB

GENB — GENERATE BIOMEDICINES INC

申报持仓市值$1.89B
持有基金数(最新)131
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)92
机构持仓市值$1.79B · 108.21M 股
新建/增持/减仓/清仓44 / 26 / 11 / 15 · 更新于 2026-11-14
前五大/前十大集中度75.1% / 84.1%
机构整体持仓变动 增持 +1.7% (+1.73M 股)
机构持仓市值变动 上升 +37.6%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 92 家机构在其最新 13F 申报中持有 GENB(GENERATE BIOMEDICINES INC),合计申报市值 $1.79B,对应 108.21M 股。按股数计算较上季度增持 1.7%(+1.73M 股),申报市值环比上升 37.6%。持仓集中度较高:前五大持有人占申报市值的 75.1%,前十大的集中度为 84.1%。

与上一季度相比,44 家新建仓位、26 家加仓、11 家减仓、15 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

GENERATE BIOMEDICINES INC(GENB)的主要机构持有人包括 Flagship Pioneering, LLC、Fidelity Management & Research (FMR)、Capital World Investors,按 13F 申报市值在本页 131 家持有人中排名居前。

GENB 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

持有 GENB 的传奇投资人

我们追踪的超级投资人在各自最新 13F 申报中持有 GENB 的名单——每位投资人按其自身最近一个季度展示。

投资人 季度 股数 金额 组合权重 变化
方舟投资 Q3 2026 1.96M $29.51M 0.17% 增持

这些投资人共同持有哪些股票?→  ·  嵌入此组件 →

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 69 27.72M $417.54M +26.6%
Q2 2026 92 108.21M $1.79B +1.7%
Q1 2026 63 100.53M $1.23B —

表内 3 个季度中,机构持股合计减少 72%(Q1 2026 → Q3 2026)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 7.19M $107.94M 0.01% 增持
Capital World Investors 4.20M $63.11M 0.01% 持有
JPMorgan Chase & Co 2.65M $40.94M 0.01% 增持
VANGUARD CAPITAL MANAGEMENT LLC 2.24M $33.58M 0.00% 增持
ARK Invest 1.96M $29.51M 0.17% 增持
BlackRock Inc 1.83M $27.49M 0.00% 增持
BANQUE PICTET & CIE SA 历史持仓 1.77M $26.63M 0.39% 新进
Davern Capital Partners, LP 历史持仓 824.68K $12.39M 2.41% 持有
Siren, L.L.C. 736.10K $11.06M 0.26% 持有
Geode Capital Management 729.08K $10.95M 0.00% 减持
STATE STREET CORP 546.34K $8.21M 0.00% 新进
Morgan Stanley 522.41K $7.85M 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 204.18K $3.07M 0.00% 增持
TD ASSET MANAGEMENT INC 180.00K $2.78M 0.00% 增持
ALPS ADVISORS INC 170.04K $2.55M 0.01% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 169.76K $2.55M 0.00% 增持
Prosight Management, LP 历史持仓 144.76K $2.17M 0.42% 新进
Savant Capital, LLC 139.42K $2.09M 0.01% 新进
UBS Group AG 126.95K $1.91M 0.00% 减持
Quadrature Capital Ltd 120.30K $1.81M 0.01% 增持
BARCLAYS PLC 118.47K $1.78M 0.00% 增持
Manulife Financial 115.99K $1.74M 0.00% 增持
Affinity Asset Advisors, LLC 100.00K $1.50M 0.07% 减持
Nuveen, LLC 85.28K $1.28M 0.00% 增持
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84.96K $1.28M 0.08% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Flagship Pioneering, LLC 历史持仓 62.67M $1.06B 68.66% 持有
Fidelity Management & Research (FMR) 5.22M $88.09M 0.00% 增持
Capital World Investors 4.22M $71.12M 0.01% 增持
Capital World Investors 4.22M $71.12M 0.01% 增持
BRAIDWELL LP 历史持仓 3.28M $55.40M 2.18% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 2.16M $36.38M 0.00% 增持
Norges Bank Investment Management 2.09M $35.34M 0.00% 新进
ARCH Venture Management, LLC 历史持仓 1.94M $32.80M 2.98% 持有
HARBOURVEST PARTNERS LLC 历史持仓 1.72M $29.05M 17.09% 持有
BlackRock Inc 1.66M $28.00M 0.00% 新进
BAKER BROS. ADVISORS LP 1.42M $24.02M 0.13% 持有
JPMorgan Chase & Co 1.41M $23.84M 0.00% 减持
Deep Track Capital, LP 1.33M $22.50M 0.34% 新进
ARK Invest 1.28M $21.67M 0.14% 增持
VANGUARD CAPITAL MANAGEMENT LLC 1.13M $19.11M 0.00% 增持
Harvard Management Company 历史持仓 1.11M $18.74M 0.91% 持有
HARVARD MANAGEMENT CO INC 1.11M $18.74M 0.44% 持有
NVIDIA CORP 历史持仓 833.33K $14.06M 0.02% 持有
Davern Capital Partners, LP 历史持仓 824.68K $13.91M 2.37% 增持
Siren, L.L.C. 736.10K $12.42M 0.25% 持有
GEODE CAPITAL MANAGEMENT, LLC 735.00K $12.40M 0.00% 新进
Geode Capital Management 735.00K $12.40M 0.00% 增持
Affinity Asset Advisors, LLC 400.00K $6.75M 0.33% 增持
Morgan Stanley 377.99K $6.38M 0.00% 增持
UBS Group AG 326.27K $5.50M 0.00% 减持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Flagship Pioneering, LLC 历史持仓 62.67M $783.41M 67.44% 新进
Fidelity Management & Research (FMR) 4.22M $52.72M 0.00% 新进
Capital World Investors 4.00M $50.05M 0.01% 新进
Capital World Investors 4.00M $50.05M 0.01% 新进
BRAIDWELL LP 历史持仓 3.59M $44.91M 1.70% 新进
JPMorgan Chase & Co 2.95M $33.92M 0.00% 新进
PRICE T ROWE ASSOCIATES INC /MD/ 2.11M $26.37M 0.00% 新进
ARCH Venture Management, LLC 历史持仓 1.94M $24.31M 3.59% 新进
HARBOURVEST PARTNERS LLC 历史持仓 1.72M $21.53M 21.33% 新进
BAKER BROS. ADVISORS LP 1.42M $17.80M 0.11% 新进
Harvard Management Company 历史持仓 1.11M $13.89M 0.77% 新进
HARVARD MANAGEMENT CO INC 1.11M $13.89M 0.77% 新进
NVIDIA CORP 历史持仓 833.33K $10.42M 0.06% 新进
Siren, L.L.C. 736.10K $9.20M 0.26% 新进
Davern Capital Partners, LP 历史持仓 591.80K $7.40M 2.03% 新进
Alyeska Investment Group, L.P. 500.00K $6.25M 0.02% 新进
ARK Invest 498.41K $6.23M 0.05% 新进
Millennium Management 376.89K $4.71M 0.00% 新进
MILLENNIUM MANAGEMENT LLC 376.89K $4.71M 0.01% 新进
UBS Group AG 356.70K $4.46M 0.00% 新进
Affinity Asset Advisors, LLC 350.00K $4.38M 0.23% 新进
Morgan Stanley 337.30K $4.22M 0.00% 新进
ExodusPoint Capital Management, LP 311.99K $3.90M 0.04% 新进
CenterBook Partners LP 266.81K $3.34M 0.18% 新进
SPHERA FUNDS MANAGEMENT LTD. 185.00K $2.31M 0.38% 新进

查看全部 131 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026
Fidelity Management & Research (FMR) 7.19M 5.22M 4.22M
Capital World Investors 4.20M 4.22M 4.00M
JPMorgan Chase & Co 2.65M 1.41M 2.95M
VANGUARD CAPITAL MANAGEMENT LLC 2.24M 1.13M 131.32K
ARK Invest 1.96M 1.28M 498.41K
BlackRock Inc 1.83M 1.66M —
BANQUE PICTET & CIE SA 1.77M — —
Davern Capital Partners, LP 824.68K 824.68K 591.80K
Siren, L.L.C. 736.10K 736.10K 736.10K
Geode Capital Management 729.08K 735.00K 118.24K
STATE STREET CORP 546.34K — —
Morgan Stanley 522.41K 377.99K 337.30K
VANGUARD FIDUCIARY TRUST CO 204.18K 175.36K 17.46K
TD ASSET MANAGEMENT INC 180.00K 50.75K 42.87K
ALPS ADVISORS INC 170.04K 129.41K —
VANGUARD PORTFOLIO MANAGEMENT LLC 169.76K 167.28K —
Prosight Management, LP 144.76K — —
Savant Capital, LLC 139.42K — —
UBS Group AG 126.95K 326.27K 356.70K
Quadrature Capital Ltd 120.30K 31.51K —

下载持有人名单 (CSV)

常见问题

Which funds hold GENB?

As of 2026-Q2, 92 institutional funds reported holding GENB (GENERATE BIOMEDICINES INC) in SEC 13F filings, with a combined reported value of $1.79B.

How many shares of GENB do institutions own?

13F filers reported 108.21M shares of GENB, worth $1.79B in aggregate at the end of 2026-Q2.

Is institutional ownership of GENB rising or falling?

Share counts moved +1.7% versus the prior quarter — accumulation.

Who are the top institutional holders of GENB?

The largest 13F holders are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of GENERATE BIOMEDICINES INC?

The major shareholders of GENERATE BIOMEDICINES INC (GENB) by reported 13F value are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP, among 131 institutional holders.

Which legendary investors own GENB?

1 of the legendary investors tracked on HoldingsHub report GENB (GENERATE BIOMEDICINES INC) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on GENB?

1 tracked superinvestors hold GENB simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 GENB」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/GENB/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →